Work

Abstract PD3-11: Overcoming ADC Resistance: Payload Diversification as a Strategy for Sequential Therapy

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd3-11

Authors: D. Rampa, N. Ogata, N. Sridhar, F. Takeo, C. Wannaphut, J. Maynard, K. Tsuchikama, G. Sledge, N. Ueno, J. Lee

Institutions: University of Hawaii Cancer Center, Baylor College of Medicine, National Institutes of Health, National Cancer Institute, University of Hawaiʻi at Mānoa, The University of Texas at Austin, The University of Texas Health Science Center at Houston, Caris Life Sciences (United States)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129568648

Cites:

Cited by:

Related to: